UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection

Psychoneuroendocrinology, 2023-07, Vol.153, p.106104-106104, Article 106104

2023

Volltextzugriff (PDF)

Why Has Model‐Informed Precision Dosing Not Yet Become Common Clinical Reality? Lessons From the Past and a Roadmap for the Future

Clinical pharmacology and therapeutics, 2017-05, Vol.101 (5), p.646-656

2017

Volltextzugriff (PDF)

Influence of the paraoxonase‐1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta‐analysis

Journal of thrombosis and haemostasis, 2012-07, Vol.10 (7), p.1242-1251

2012

Volltextzugriff (PDF)

Use of the PFA‐100™ closure time to predict cardiovascular events in aspirin‐treated cardiovascular patients: a systematic review and meta‐analysis

Journal of thrombosis and haemostasis, 2008-03, Vol.6 (3), p.444-450

2008

Volltextzugriff (PDF)

Frequency of Abnormally Low Neuropsychological Scores in Post-COVID-19 Syndrome: the Geneva COVID-COG Cohort

Archives of clinical neuropsychology, 2023-01, Vol.38 (1), p.1-11

2023

Volltextzugriff (PDF)

Prothrombin G20210A Mutation and Lower Extremity Peripheral Arterial Disease: A Systematic Review and Meta-analysis

European journal of vascular and endovascular surgery, 2015-08, Vol.50 (2), p.232-240

2015

Volltextzugriff (PDF)

Functional Independence Measure score is associated with mortality in critically ill elderly patients admitted to an intermediate care unit

BMC geriatrics, 2020-09, Vol.20 (1), p.334-334, Article 334

2020

Volltextzugriff (PDF)

Relationship between paraoxonase‐1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study

Journal of thrombosis and haemostasis, 2011-08, Vol.9 (8), p.1664-1666

2011

Volltextzugriff (PDF)

Antiplatelet Therapy: Targeting the TxA2 Pathway

Journal of cardiovascular translational research, 2014-02, Vol.7 (1), p.29-38

2014

Volltextzugriff (PDF)

Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach

Clinical pharmacology and therapeutics, 2016-09, Vol.100 (3), p.295-304

2016

Volltextzugriff (PDF)

The paraoxonase‐1 pathway is not a major bioactivation pathway of clopidogrel in vitro

British journal of pharmacology, 2012-08, Vol.166 (8), p.2362-2370

2012

Volltextzugriff (PDF)

Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study

Journal of thrombosis and haemostasis, 2010-12, Vol.8 (12), p.2614-2623

2010

Volltextzugriff (PDF)

New Antiplatelet Strategies in Atherothrombosis and Their Indications

European journal of vascular and endovascular surgery, 2007-07, Vol.34 (1), p.10-17

2007

Volltextzugriff (PDF)

The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies

Journal of thrombosis and haemostasis, 2005-07, Vol.3 (7), p.1437-1445

2005

Volltextzugriff (PDF)

Clinical implications of clopidogrel non‐response in cardiovascular patients: a systematic review and meta‐analysis

Journal of thrombosis and haemostasis, 2010-05, Vol.8 (5), p.923-933

2010

Volltextzugriff (PDF)

Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided?

Journal of thrombosis and haemostasis, 2009-02, Vol.7 (2), p.363-364

2009

Volltextzugriff (PDF)

Individual Smallest Detectable Difference in Bone Mineral Density Measurements

Journal of bone and mineral research, 1999-08, Vol.14 (8), p.1449-1456

1999

Volltextzugriff (PDF)

Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104]

Psychoneuroendocrinology, 2023-09, Vol.155, p.106324-106324, Article 106324

2023

Volltextzugriff (PDF)

Accuracy of comprehensive PCR analysis of nasopharyngeal and oropharyngeal swabs for CT-scan-confirmed pneumonia in elderly patients: a prospective cohort study

Clinical microbiology and infection, 2019-09, Vol.25 (9), p.1114-1119

2019

Volltextzugriff (PDF)

The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case–control study

Journal of thrombosis and haemostasis, 2004-08, Vol.2 (8), p.1334-1340

2004

Volltextzugriff (PDF)

Role of paraoxonase-1 in CYP2C19 loss-of-function carriers

Thrombosis research, 2014-03, Vol.133 (3), p.519-519

2014

Volltextzugriff (PDF)

Antiagrégants plaquettaires : lequel, quand et pour qui ?

La Revue de médecine interne (Paris), 2010-12, Vol.31, p.S339-S341

2010

Volltextzugriff (PDF)

Une histoire pas très originale dans un contexte pas très confortable

La revue de medecine interne, 2011, Vol.32 (1), p.50-53

2011

Volltextzugriff (PDF)

Hemoptysis in a 55-year-old man

La revue de medecine interne, 2011-01, Vol.32 (1), p.50-53

2011

Volltextzugriff (PDF)

4CPS-369 PharmaCheck as a screening tool to intercept high risk situations in internal medicine that could lead to adverse drug events

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A98-A98

2021

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(116)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(72)
Science & Technology
(49)
Life Sciences & Biomedicine
(47)
Male
(35)
Female
(23)
Cardiovascular System & Cardiology
(21)
Peripheral Vascular Disease
(21)
Middle Aged
(19)
Adult
(17)
Hematology
(16)
Aged
(15)
Biological And Medical Sciences
(15)
Medical Sciences
(14)
Platelet Aggregation Inhibitors - Therapeutic Use
(14)
Risk Factors
(12)
General & Internal Medicine
(11)
Sciences Biologiques Et Medicales
(11)
Sciences Medicales
(11)
Medicine, General & Internal
(10)
Adolescent
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection

Why Has Model‐Informed Precision Dosing Not Yet Become Common Clinical Reality? Lessons From the Past and a Roadmap for the Future

Influence of the paraoxonase‐1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta‐analysis

Use of the PFA‐100™ closure time to predict cardiovascular events in aspirin‐treated cardiovascular patients: a systematic review and meta‐analysis

Frequency of Abnormally Low Neuropsychological Scores in Post-COVID-19 Syndrome: the Geneva COVID-COG Cohort

Prothrombin G20210A Mutation and Lower Extremity Peripheral Arterial Disease: A Systematic Review and Meta-analysis

Functional Independence Measure score is associated with mortality in critically ill elderly patients admitted to an intermediate care unit

Relationship between paraoxonase‐1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study

Antiplatelet Therapy: Targeting the TxA2 Pathway

Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach

The paraoxonase‐1 pathway is not a major bioactivation pathway of clopidogrel in vitro

Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study

New Antiplatelet Strategies in Atherothrombosis and Their Indications

The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies

Clinical implications of clopidogrel non‐response in cardiovascular patients: a systematic review and meta‐analysis

Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided?

Individual Smallest Detectable Difference in Bone Mineral Density Measurements

Corrigendum to “Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection” [Psychoneuroendocrinology 153 (2023) 106104]

Accuracy of comprehensive PCR analysis of nasopharyngeal and oropharyngeal swabs for CT-scan-confirmed pneumonia in elderly patients: a prospective cohort study

The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case–control study

Role of paraoxonase-1 in CYP2C19 loss-of-function carriers

Antiagrégants plaquettaires : lequel, quand et pour qui ?

Une histoire pas très originale dans un contexte pas très confortable

Hemoptysis in a 55-year-old man

4CPS-369 PharmaCheck as a screening tool to intercept high risk situations in internal medicine that could lead to adverse drug events

Suchergebnisse filtern